Correlation Between HCW Biologics and Cingulate Warrants

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Cingulate Warrants at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Cingulate Warrants into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HCW Biologics and Cingulate Warrants, you can compare the effects of market volatilities on HCW Biologics and Cingulate Warrants and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Cingulate Warrants. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Cingulate Warrants.

Diversification Opportunities for HCW Biologics and Cingulate Warrants

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between HCW and Cingulate is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Cingulate Warrants in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cingulate Warrants and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Cingulate Warrants. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cingulate Warrants has no effect on the direction of HCW Biologics i.e., HCW Biologics and Cingulate Warrants go up and down completely randomly.

Pair Corralation between HCW Biologics and Cingulate Warrants

Given the investment horizon of 90 days HCW Biologics is expected to generate 3.45 times more return on investment than Cingulate Warrants. However, HCW Biologics is 3.45 times more volatile than Cingulate Warrants. It trades about 0.13 of its potential returns per unit of risk. Cingulate Warrants is currently generating about 0.01 per unit of risk. If you would invest  44.00  in HCW Biologics on August 30, 2024 and sell it today you would earn a total of  6.00  from holding HCW Biologics or generate 13.64% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

HCW Biologics  vs.  Cingulate Warrants

 Performance 
       Timeline  
HCW Biologics 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in HCW Biologics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, HCW Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.
Cingulate Warrants 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cingulate Warrants has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly fragile technical and fundamental indicators, Cingulate Warrants may actually be approaching a critical reversion point that can send shares even higher in December 2024.

HCW Biologics and Cingulate Warrants Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HCW Biologics and Cingulate Warrants

The main advantage of trading using opposite HCW Biologics and Cingulate Warrants positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Cingulate Warrants can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate Warrants will offset losses from the drop in Cingulate Warrants' long position.
The idea behind HCW Biologics and Cingulate Warrants pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios